Krishna Gopal Gupta & Sons (HUF)

Krishna Gopal Gupta & Sons (HUF) appears in our data through filings on GKB Ophthalmics shares, published by SEBI (PIT + SAST). Activity is concentrated on a single trading day, 30 June 2026, with 5 filings.

The open-market record is one-sided, with 5 purchases worth €599 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €95. Measured against the company's value, the median purchase equals 0.0031% of market capitalisation, across 5 purchases where it is known. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +2.5%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 30 June 2026, the filings show an open-market purchase worth €186 in GKB Ophthalmics. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.